AI assistant
TALPHERA, INC. — Director's Dealing 2024
Feb 27, 2024
35181_dirs_2024-02-27_552c35c3-ef3d-4dde-b57f-949a19178109.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TALPHERA, INC. (TLPH)
CIK: 0001427925
Period of Report: 2024-02-14
Reporting Person: Palmer Pamela P (Director, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-14 | Common Stock | A | 18000 | $0.00 | Acquired | 53344 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-14 | Stock Option (Right to Buy) | $1.03 | A | 108000 | Acquired | 2034-02-13 | Common Stock (108000) | Direct |
Footnotes
F1: The restricted stock units shall vest in three equal consecutive annual installments on February 14, 2025, February 14, 2026 and February 14, 2027.
F2: On February 14, 2024, the reporting person was granted an option to purchase 108,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.